Triplet Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer

被引：0

作者：

Hindie, Elif ^{[1
]}

机构：

[1] Bordeaux Univ Hosp, Dept Nucl Med, Bordeaux, France

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 22期

关键词：

PD-L1; TIGIT; PEMBROLIZUMAB;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：3873 / 3875

页数：3

共 28 条

[1] Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study [J].

Antonarakis, Emmanuel S. ;

Piulats, Josep M. ;

Gross-Goupil, Marine ;

Goh, Jeffrey ;

Ojamaa, Kristiina ;

Hoimes, Christopher J. ;

Vaishampayan, Ulka ;

Berger, Ranaan ;

Sezer, Ahmet ;

Alanko, Tuomo ;

de Wit, Ronald ;

Li, Chunde ;

Omlin, Aurelius ;

Procopio, Giuseppe ;

Fukasawa, Satoshi ;

Tabata, Ken-ichi ;

Park, Se Hoon ;

Feyerabend, Susan ;

Drake, Charles G. ;

Wu, Haiyan ;

Qiu, Ping ;

Kim, Jeri ;

Poehlein, Christian ;

de Bono, Johann Sebastian .

JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (05)

[2] Mechanistic convergence of the TIGIT and PD-1 inhibitory pathways necessitates co-blockade to optimize anti-tumor CD8+ T cell responses [J].

Banta, Karl L. ;

Xu, Xiaozheng ;

Chitre, Avantika S. ;

Au-Yeung, Amelia ;

Takahashi, Chikara ;

O'Gorman, William E. ;

Wu, Thomas D. ;

Mittman, Stephanie ;

Cubas, Rafael ;

Comps-Agrar, Laetitia ;

Fulzele, Amit ;

Bennett, Eric J. ;

Grogan, Jane L. ;

Hui, Enfu ;

Chiang, Eugene Y. ;

Mellman, Ira .

IMMUNITY, 2022, 55 (03) :512-+

[3] PD-L1 is highly expressed in Enzalutamide resistant prostate cancer [J].

Bishop, Jennifer L. ;

Sio, Alexander ;

Angeles, Arkhjamil ;

Roberts, Morgan E. ;

Azad, Arun A. ;

Chi, Kim N. ;

Zoubeidi, Amina .

ONCOTARGET, 2015, 6 (01) :234-242

[4]

Clarke Noel W, 2022, NEJM Evid, V1, pEVIDoa2200043, DOI 10.1056/EVIDoa2200043

[5] Final overall survival (OS) in PROpel: Abiraterone (abi) and olaparib (ola) versus abiraterone and placebo (pbo) as first-line (1L) therapy for metastatic castration-resistant prostate cancer (mCRPC). [J].

不详 .

JOURNAL OF CLINICAL ONCOLOGY, 2023, 41

[6] Olaparib for Metastatic Castration-Resistant Prostate Cancer [J].

de Bono, J. ;

Mateo, J. ;

Fizazi, K. ;

Saad, F. ;

Shore, N. ;

Sandhu, S. ;

Chi, K. N. ;

Sartor, O. ;

Agarwal, N. ;

Olmos, D. ;

Thiery-Vuillemin, A. ;

Twardowski, P. ;

Mehra, N. ;

Goessl, C. ;

Kang, J. ;

Burgents, J. ;

Wu, W. ;

Kohlmann, A. ;

Adelman, C. A. ;

Hussain, M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (22) :2091-2102

[7] Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer [J].

de Wit, Ronald ;

de Bono, Johann ;

Sternberg, Cora N. ;

Fizazi, Karim ;

Tombal, Bertrand ;

Wuelfing, Christian ;

Kramer, Gero ;

Eymard, Jean-Christophe ;

Bamias, Aristotelis ;

Carles, Joan ;

Iacovelli, Roberto ;

Melichar, Bohuslav ;

Sverrisdottir, Asgerdur ;

Theodore, Christine ;

Feyerabend, Susan ;

Helissey, Carole ;

Ozatilgan, Ayse ;

Geffriaud-Ricouard, Christine ;

Castellano, Daniel ;

de Wit, Ronald ;

de Bono, Johann ;

Sternberg, Cora N. ;

Fizazi, Karim ;

Tombal, Bertrand ;

Wulfing, Christian ;

Kramer, Gero ;

Eymard, Jean-Christophe ;

Bamias, Aristotelis ;

Carles, Joan ;

Iacovelli, Roberto ;

Melichar, Bohuslav ;

Sverrisdottir, Asgerour ;

Theodore, Christine ;

Feyerabend, Susan ;

Helissey, Carole ;

Ozatilgan, Ayse ;

Geffriaud-Ricouard, Christine ;

Castellano, Daniel .

NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (26) :2506-2518

[8] Oncological Response and Predictive Biomarkers for the Checkpoint Inhibitors in Castration-Resistant Metastatic Prostate Cancer: A Systematic Review and Meta-Analysis [J].

Fahmy, Omar ;

Alhakamy, Nabil A. ;

Khairul-Asri, Mohd G. ;

Ahmed, Osama A. A. ;

Fahmy, Usama A. ;

Fresta, Claudia G. ;

Caruso, Giuseppe .

JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (01)

[9]

George DJ, 2020, CLIN GENITOURIN CANC, V18, P284, DOI [10.1016/j.clgc.2020.12.019, 10.1016/j.clgc.2019.12.019]

[10] The Immune Checkpoint Regulator PD-L1 Is Highly Expressed in Aggressive Primary Prostate Cancer [J].

Gevensleben, Heidrun ;

Dietrich, Dimo ;

Golletz, Carsten ;

Steiner, Susanne ;

Jung, Maria ;

Thiesler, Thore ;

Majores, Michael ;

Stein, Johannes ;

Uhl, Barbara ;

Mueller, Stefan ;

Ellinger, Joerg ;

Stephan, Carsten ;

Jung, Klaus ;

Brossart, Peter ;

Kristiansen, Glen .

CLINICAL CANCER RESEARCH, 2016, 22 (08) :1969-1977

← 1 2 3 →